Settings Today

Updated data from Covaxin phase 3 trial shows 78% efficacy

The efficacy against severe COVID-19 disease was 100%, Bharat Biotech claimed, but that against protecting from asymptomatic COVID-19 infection was 70%

Published 1112 days ago

Go Back to Reading NewsBack Read News Collect this News Article

© 2024 - ErnesTech - Privacy
E-Commerce Return Policy